Across TCGA pan-cancer cohorts, H3C9P Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated H3C9P data layer compared with 23 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher H3C9P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated H3C9P expression acts as an unfavorable survival marker.

UCEC and LUAD are the cancer types where H3C9P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	All	0.506	0.928	<.001	26	view →
LUAD	DFS	Median	All	0.178	0.813	<.001	21	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: H3C9P tumor-vs-normal RNA expression · all H3C9P data types